GB202016955D0 - Therapeutic treatments - Google Patents
Therapeutic treatmentsInfo
- Publication number
- GB202016955D0 GB202016955D0 GBGB2016955.3A GB202016955A GB202016955D0 GB 202016955 D0 GB202016955 D0 GB 202016955D0 GB 202016955 A GB202016955 A GB 202016955A GB 202016955 D0 GB202016955 D0 GB 202016955D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic treatments
- treatments
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2016955.3A GB202016955D0 (en) | 2020-10-26 | 2020-10-26 | Therapeutic treatments |
JP2022567230A JP2023525512A (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds used in the treatment of COVID-19 |
BR112022022515A BR112022022515A2 (en) | 2020-05-05 | 2021-04-30 | METHYLTHIONIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19 |
US17/997,758 US20230165875A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of covid-19 |
EP21723699.1A EP4146223A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of covid-19 |
PCT/EP2021/061480 WO2021224144A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of covid-19 |
KR1020227042294A KR20230012514A (en) | 2020-05-05 | 2021-04-30 | treatment method |
CN202180043773.6A CN116056724A (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for the treatment of covd-19 |
AU2021267670A AU2021267670A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of COVID-19 |
MX2022013883A MX2022013883A (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of covid-19. |
CA3181393A CA3181393A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of covid-19 |
TW110116179A TW202200150A (en) | 2020-05-05 | 2021-05-05 | Therapeutic treatments |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2016955.3A GB202016955D0 (en) | 2020-10-26 | 2020-10-26 | Therapeutic treatments |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202016955D0 true GB202016955D0 (en) | 2020-12-09 |
Family
ID=73727097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2016955.3A Ceased GB202016955D0 (en) | 2020-05-05 | 2020-10-26 | Therapeutic treatments |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202016955D0 (en) |
-
2020
- 2020-10-26 GB GBGB2016955.3A patent/GB202016955D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202001980D0 (en) | Therapeutic mentods | |
GB202006960D0 (en) | Therapeutic | |
GB202108303D0 (en) | Therapy | |
GB202111288D0 (en) | Combination therapy | |
GB202004189D0 (en) | Combination therapy | |
GB202016955D0 (en) | Therapeutic treatments | |
GB202006659D0 (en) | Therapeutic treatments | |
GB202117706D0 (en) | Therapy | |
GB202111035D0 (en) | Therapy | |
GB202109893D0 (en) | PeptiBAC therapy | |
GB202104427D0 (en) | Therapy | |
GB202103164D0 (en) | Therapy | |
GB202102211D0 (en) | PeptiBAC therapy | |
GB202019218D0 (en) | Therapy | |
GB202017598D0 (en) | Therapy | |
GB202017554D0 (en) | Therapy | |
GB202110329D0 (en) | Therapeutic | |
GB202015780D0 (en) | Therapy | |
GB202015778D0 (en) | Therapy | |
GB202013834D0 (en) | PeptiVAX therapy | |
GB202013824D0 (en) | PeptiBAC therapy | |
GB202009039D0 (en) | Therapy | |
GB202008031D0 (en) | Therapy | |
GB202004629D0 (en) | Therapy | |
GB202004013D0 (en) | Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |